[ Price : $8.95]
Millenium: The Takeda Oncology Co. and Seattle Genetics initiate a Phase 3 clinical study of Adcetris as part of a chemotherapy re...[ Price : $8.95]
FDAs order last month for Teva to withdraw its generic bupropion extended-release 300mg product prompts the agency to pay closer a...[ Price : $8.95]
BioCryst Pharmaceuticals withdraws its IND for the antiviral nucleoside, BCX5191 after FDA expressed concerns about its preclinica...[ Price : $8.95]
Navidea Biopharmaceuticals resubmits its Lymphoseek NDA to FDA to answer agency questions about third-party cGMPs.[ Price : $8.95]
Ameridose, the sister company of troubled New England Compounding Center, recalls all unexpired products remaining in circulation ...[ Price : $8.95]
Biogen Idec plans to submit a BLA in the first half of 2013 for a long-lasting recombinant Factor VIII Fc fusion protein (rFVIIIFc...[ Price : $8.95]
CDRH says it is puzzled by an increase in Class 1 medical device recalls seen over the past four years.[ Price : $8.95]
Attorney Mimi Davis says the learned intermediary doctrine may be a defense in failure-to-warn cases being tried under Florida law...